T2 Biosystems, Inc. - Common Stock (TTOO)
0.2150
+0.0050 (2.38%)
T2 Biosystems is a biotechnology company focused on transforming the way infectious diseases are diagnosed
The company's innovative molecular diagnostic platform enables rapid and accurate detection of a wide range of pathogens, including bacteria and fungi, using blood samples. By providing timely results, T2 Biosystems aims to enhance clinical decision-making, improve patient outcomes, and reduce the overall burden of infectious diseases. Their commitment to developing advanced diagnostic tools positions them as a leader in the field of point-of-care testing and infectious disease management.
Frequently Asked Questions
Is T2 Biosystems, Inc. - Common Stock publicly traded?
Yes, T2 Biosystems, Inc. - Common Stock is publicly traded.
What exchange does T2 Biosystems, Inc. - Common Stock trade on?
T2 Biosystems, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for T2 Biosystems, Inc. - Common Stock?
The ticker symbol for T2 Biosystems, Inc. - Common Stock is TTOO on the Nasdaq Stock Market
What is the current price of T2 Biosystems, Inc. - Common Stock?
The current price of T2 Biosystems, Inc. - Common Stock is 0.2150
When was T2 Biosystems, Inc. - Common Stock last traded?
The last trade of T2 Biosystems, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of T2 Biosystems, Inc. - Common Stock?
The market capitalization of T2 Biosystems, Inc. - Common Stock is 5.35M
How many shares of T2 Biosystems, Inc. - Common Stock are outstanding?
T2 Biosystems, Inc. - Common Stock has 24.89M shares outstanding.